# FDA Inspection 1264015 - Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site) - March 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/shandong-anxin-pharmaceutical-co-ltd-laoling-site/1b6d8af0-e35d-4b09-ac95-6aaae754c9c6
Source feed: FDA_Inspections

> FDA Inspection 1264015 for Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site) on March 14, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264015
- Company Name: Shandong Anxin Pharmaceutical Co., Ltd. (Laoling site)
- Inspection Date: 2025-03-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1264015 - 2025-03-14](https://www.keypedia.com/records/fda_inspections/shandong-anxin-pharmaceutical-co-ltd-laoling-site/5727875a-30a8-41ee-b803-a8c227da1ec2)

Company: https://www.keypedia.com/companies/shandong-anxin-pharmaceutical-co-ltd-laoling-site/8ecae9ce-7b8b-40b5-99de-92a6859f9683

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c